← Eichor
Condition: Gastric Cancer Peritoneal Metastases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gastric Cancer Peritoneal Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperth
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06685887INTERACT Stomach-II
Phase 2 · 3 location(s) · Erasmus Medical Center · NCT07133490Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07001592The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Periton
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06597526Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Phase N/A · 13 location(s) · Chinese Academy of Sciences · NCT05722275Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06308510Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Periton
Phase 2 · 1 location(s) · Mayo Clinic · NCT05753306A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT05347524Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal
Phase 3 · 7 location(s) · Magnus Nilsson · NCT07304271Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advance
Phase 2 · 1 location(s) · University of Chicago · NCT04107077PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gast
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT04329494Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06675136Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatm
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06519591LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroes
Phase 2 · 1 location(s) · Ruijin Hospital · NCT07556640Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
Phase N/A · 1 location(s) · Ukrainian Society of Clinical Oncology · NCT07313579
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.